Charabi S, Tos M, Thomsen J, Charabi B, Mantoni M
Department of Otolaryngology, Head and Neck Surgery, Gentofte University Hospital, Hellerup, Denmark.
Laryngoscope. 2000 Oct;110(10 Pt 1):1720-5. doi: 10.1097/00005537-200010000-00030.
To investigate the growth of vestibular schwannoma (VS) in a series of 123 patients with 127 tumors allocated to the "wait and scan" group in the period 1973-1999.
Retrospective review of prospectively registered data on all patients with VSIE from the entire country who were allocated to the wait and scan group.
Clinical charts, audiometric data, and neuroradiological images were reviewed and tabulated for age, hearing level expressed as speech reception threshold (SRT) and speech discrimination score (SDS), maximum extra-canalicular tumor extension, and possible changes in tumor diameter. The material was updated three times (in June 1993, June 1996, and June 1999). Via the Danish national register, data on whether the included patients were alive or dead were collected in 1999.
The tumor growth, growth rate, and growth patterns were calculated in three periods 1973 to 1993 (mean observation period, 3.4 y), 1973 to 1996 (mean observation period, 3.8 y), and from 1973 to 1999 (mean observation period, 4.2 y). By termination of the first period, 94 tumors (74%) exhibited measurable growth, 23 tumors (18%) no measurable growth, and 10 tumors (8%) revealed negative growth. By the end of the extended observation period, tumor growth was observed in 104 tumors (82%), no tumor growth in 15 tumors (12%), and negative growth in 8 tumors (6%). Subsequent to the third observation period, growth was observed in 108 tumors (85%), no growth in 11 tumors (9%) and negative growth in 8 tumors (6%). However, the results may also be interpreted in another way: 52 patients (42%) were alive at the time of writing, tumor growth did not demand any intervention, 23 patients (19%) died as a result of non-tumor-related causes, and 35 patients (28%) were previously treated and alive by the termination of the third observation period.
Depending on the observation period, three sets of growth results were obtained. The long observation period, updating and re-updating the results, gave us the opportunity for a de novo interpretation of the results and the long-term consequences of the wait and scan policy. Combined with other factors, the achieved results should be considered when timing of surgery is to be decided.
调查1973年至1999年期间123例患有127个肿瘤的患者,这些患者被分配到“等待观察并扫描”组,研究前庭神经鞘瘤(VS)的生长情况。
对全国所有被分配到等待观察并扫描组的VSIE患者的前瞻性登记数据进行回顾性分析。
查阅临床病历、听力测定数据和神经放射影像,并将年龄、以言语接受阈值(SRT)和言语辨别得分(SDS)表示的听力水平、肿瘤最大外耳道外扩展情况以及肿瘤直径可能的变化制成表格。资料更新了三次(1993年6月、1996年6月和1999年6月)。通过丹麦国家登记处,收集了1999年纳入患者的存活或死亡数据。
计算了1973年至1993年(平均观察期3.4年)、1973年至1996年(平均观察期3.8年)以及1973年至1999年(平均观察期4.2年)三个时间段的肿瘤生长、生长速率和生长模式。在第一个时间段结束时,94个肿瘤(74%)有可测量的生长,23个肿瘤(18%)无可测量的生长,10个肿瘤(8%)呈负生长。在延长观察期结束时,104个肿瘤(82%)观察到肿瘤生长,15个肿瘤(12%)无肿瘤生长,8个肿瘤(6%)呈负生长。在第三个观察期之后,108个肿瘤(85%)观察到生长,11个肿瘤(9%)无生长,8个肿瘤(6%)呈负生长。然而,结果也可以用另一种方式解释:52例患者(42%)在撰写本文时存活,肿瘤生长无需任何干预,23例患者(19%)因非肿瘤相关原因死亡,35例患者(28%)在第三个观察期结束前接受过治疗且存活。
根据观察期,获得了三组生长结果。长时间的观察期、对结果的更新和重新更新,让我们有机会重新解读结果以及等待观察并扫描策略的长期后果。在决定手术时机时,应结合其他因素考虑所取得的结果。